As of 2024-12-15, the Intrinsic Value of Bio Rad Laboratories Inc (BIO) is
406.93 USD. This BIO valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 336.28 USD, the upside of Bio Rad Laboratories Inc is
21.00%.
The range of the Intrinsic Value is 289.47 - 687.54 USD
406.93 USD
Intrinsic Value
BIO Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
289.47 - 687.54 |
406.93 |
21.0% |
| DCF (Growth 10y) |
320.28 - 702.80 |
434.33 |
29.2% |
| DCF (EBITDA 5y) |
393.81 - 472.26 |
443.52 |
31.9% |
| DCF (EBITDA 10y) |
412.50 - 534.08 |
479.20 |
42.5% |
| Fair Value |
-695.26 - -695.26 |
-695.26 |
-306.75% |
| P/E |
(791.48) - (898.27) |
(855.86) |
-354.5% |
| EV/EBITDA |
202.72 - 366.35 |
281.40 |
-16.3% |
| EPV |
58.95 - 90.58 |
74.77 |
-77.8% |
| DDM - Stable |
(226.40) - (643.75) |
(435.07) |
-229.4% |
| DDM - Multi |
(153.00) - (340.30) |
(211.31) |
-162.8% |
BIO Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
9,415.84 |
| Beta |
0.53 |
| Outstanding shares (mil) |
28.00 |
| Enterprise Value (mil) |
10,206.79 |
| Market risk premium |
4.60% |
| Cost of Equity |
9.24% |
| Cost of Debt |
5.50% |
| WACC |
8.68% |